Hana Pharm Co., Ltd.
Hana Pharm Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Eleveld PK/PD Model-based Dosing During General Anesthesia | Pharmacokinetics and Pharmacodynamics; Remimazolam | Recruiting | Phase 4 | 2026-09-29 | NCT07675850 | |
| Patient-controlled Remimazolam Sedation Under Spinal Anesthesia | Hip Arthroplasty; Patient-controlled Sedation; Remimazolam; Spinal Anesthesia | Not yet recruiting | Not applicable | 2026-09-23 | NCT07661810 | |
| Effects of Remimazolam on Postoperative Cognitive Dysfunction and Neuroinflammatory Biomarkers in Patients Undergoing Aortic Arch Surgery | Aneurysm, Aneurysm, Aortic Arch, Confusion, Emergence Delirium, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, aortic aneurysm, aortic disorder, cardiovascular disorder, cognitive disorder, delirium, nervous system disorder, psychiatric disorder, thoracic aortic aneurysm, vascular disorder | Not yet recruiting | Phase 4 | 2026-09-17 | NCT07816068 |